Shukra Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 102.86 million compared to INR 59.45 million a year ago. Revenue was INR 103.23 million compared to INR 85.73 million a year ago. Net income was INR 4.04 million compared to INR 0.563 million a year ago. Basic earnings per share from continuing operations was INR 2.58 compared to INR 0.36 a year ago. Diluted earnings per share from continuing operations was INR 2.58 compared to INR 0.36 a year ago.